Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)
- Status
- COMPLETED
- Phase
- PHASE4
Octreotide Efficacy and Safety in First-line Acromegalic Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Determine the Safety and Efficacy of Imatinib Mesylate in Patients With Idiopathic Hypereosinophilic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
- Status
- COMPLETED
- Phase
- PHASE3
Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis
- Status
- COMPLETED
- Phase
- PHASE3
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
- Status
- TERMINATED
- Phase
- PHASE3
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
- Status
- COMPLETED
- Phase
- PHASE4
An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha
- Status
- COMPLETED
- Phase
- PHASE2
An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
- Status
- COMPLETED
- Phase
- PHASE3
An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis
- Status
- COMPLETED
- Phase
- PHASE2